Picture of BioLife Solutions logo

BLFS — BioLife Solutions News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Biolife Solutions Announces 2022 Fourth Quarter And Full Year Preliminary Unaudited Revenue And Introduces 2023 Revenue Guidance

Jan 9 (Reuters) - Biolife Solutions Inc  BLFS.O :
    * BIOLIFE SOLUTIONS ANNOUNCES 2022 FOURTH QUARTER AND FULL
YEAR
PRELIMINARY UNAUDITED REVENUE AND INTRODUCES 2023 REVENUE
GUIDANCE
    * Q4 REVENUE ROSE 19 PERCENT TO $44.4 MILLION
    * INITIAL REVENUE GUIDANCE FOR 2023 OF $188 MILLION TO $202
MILLION
    * EXPECTS FULL YEAR POSITIVE ADJUSTED EBITDA AND ADJUSTED
EBITDA
GROWTH IN 2023
    * FY2023 REVENUE VIEW $195.4 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn8mvwFBa 
Further company coverage:  BLFS.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on BioLife Solutions

See all news